MENU
+Compare
UTHR
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$307.36
Change
-$4.90 (-1.57%)
Capitalization
13.8B

UTHR United Therapeutics Corp Forecast, Technical & Fundamental Analysis

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UTHR with price predictions
Apr 02, 2025

UTHR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for UTHR turned positive on March 17, 2025. Looking at past instances where UTHR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UTHR's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where UTHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UTHR advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

UTHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UTHR as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for UTHR crossed bearishly below the 50-day moving average on February 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for UTHR moved below the 200-day moving average on March 21, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UTHR entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.142) is normal, around the industry mean (13.260). P/E Ratio (12.474) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (5.181) is also within normal values, averaging (252.036).

View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 5.49% to $6.53 per share on April 30

United Therapeutics Corp UTHR Stock Earnings Reports
Q1'25
Est.
$6.53
Q4'24
Missed
by $0.49
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.63
Q1'24
Beat
by $0.38
The last earnings report on February 26 showed earnings per share of $6.19, missing the estimate of $6.68. With 431.93K shares outstanding, the current market capitalization sits at 13.80B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
HBAR.X0.1623600.000842
+0.52%
Hedera cryptocurrency
YGG.X0.172838-0.000560
-0.32%
Yield Guild Games cryptocurrency
GLM.X0.235772-0.003511
-1.47%
Golem cryptocurrency
MDX.X0.001781-0.000054
-2.93%
Mdex cryptocurrency
GHST.X0.522516-0.026588
-4.84%
Aavegotchi cryptocurrency

UTHR and Stocks

Correlation & Price change

A.I.dvisor tells us that UTHR and GERN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UTHR and GERN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-1.57%
GERN - UTHR
31%
Poorly correlated
-7.23%
DAWN - UTHR
31%
Poorly correlated
-3.14%
MNKD - UTHR
30%
Poorly correlated
-2.89%
KRYS - UTHR
29%
Poorly correlated
-1.58%
HALO - UTHR
29%
Poorly correlated
-1.76%
More

Groups containing UTHR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-1.57%
Pharmaceuticals
category (304 stocks)
15%
Poorly correlated
-1.86%